Read by QxMD icon Read

Cardiology heart failure atrial fibrillation arrhythmia coronary artery disease

Biljana Obrenović-Kirćanski, Bojana Orbović, Mile Vraneš, Biljana Parapid, Nataša Kovačević-Kostić, Miloš Velinović, Stana Ristić
Atrial fibrillation occurs as a frequent complication after cardiac interventions. It can be found in 5% of all surgical patients, and it is far more common in cardiac (10% - 65% of patients) than in non-cardiac procedures. In a number of patients it remains asymptomatic, but may be accompanied by very severe symptoms of hypotension, heart failure, syncope, systemic or pulmonary embolism, perioperative myocardial infarction, cerebrovascular insult and increased operative mortality. Patients whose postoperative course is complicated by atrial fibrillation require longer hospitalization...
July 2012: Srpski Arhiv za Celokupno Lekarstvo
Oscar Díaz-Castro, Ramón López-Palop, Tomás Datino, Manuel Martínez-Sellés
This article contains a review of the main developments in the field of geriatric cardiology reported during 2011. The principle focus is on research into the characteristics of elderly patients with heart failure, arrhythmias (e.g. into atrial fibrillation and implantable cardioverter-defibrillators), ischemic heart disease and percutaneous interventions.
January 2012: Revista Española de Cardiología
Marc Cohen, Catalin Boiangiu
The pharmacologic management of atrial fibrillation (AF) includes rate and rhythm control strategies. Antiarrhythmic agents (eg, amiodarone, flecainide, and propafenone) are limited by serious toxicities (including proarrhythmic effects and pulmonary toxicity), which may lead to a reduced net clinical efficacy of rhythm control strategies. Dronedarone, a new antiarrhythmic agent, is effective in the maintenance of sinus rhythm. Dronedarone has also been shown to reduce ventricular rate and the incidence of hospitalization due to cardiovascular events...
December 2011: Advances in Therapy
Karen Sliwa, Melinda Jane Carrington, Eric Klug, Lionel Opie, Geraldine Lee, Jocasta Ball, Simon Stewart
BACKGROUND: Little is known about the incidence and clinical characteristics of newly diagnosed atrial fibrillation/flutter (AF) in urban Africans in epidemiological transition. METHODS: This observational cohort study was carried out in the Chris Hani Baragwanath Hospital in Soweto South Africa. A clinical registry captured detailed clinical data on all de novo cases of AF presenting to the Cardiology Unit during the period 2006-2008. RESULTS: Overall, 246 of 5328 cardiac cases (4...
December 2010: Heart: Official Journal of the British Cardiac Society
Muhammad Bakhsh, Safdar Abbas, Raja Mushtaq Hussain, Safdar Ali Khan, S M Shahab Naqvi
OBJECTIVE: To assess the role of 3 days of magnesium infusion after coronary artery bypass graft (CABG) surgery in preventing postoperative atrial fibrillation (AF). PLACE AND DURATION OF STUDY: Armed Forces Institute of Cardiology (AFIC) & National Institute of Heart Diseases (NIHD), Rawalpindi, from July 2006 to June 2007. DESIGN: Prospective, randomized, non-blinded. METHODS: All patients undergoing isolated, initial CABG surgery, and having sinus rhythm before surgery were alternatively randomized into the study or the control group...
April 2009: Journal of Ayub Medical College, Abbottabad: JAMC
Nancy M Allen LaPointe, Jie-Lena Sun, Sigal Kaplan
BACKGROUND: Little is known about the use of drugs or procedures for management of atrial flutter (AFl) in routine clinical practice. We describe the extent of use of conversion therapies during AFl hospitalizations. METHODS: We examined hospitalizations for primary diagnoses of AFl using hospital claims from January 2000 to December 2004. Patients who received antiarrhythmic drugs, ablation, and/or electrical cardioversion for AFl were categorized as receiving a conversion therapy...
March 2010: American Heart Journal
Robby Nieuwlaat, Alessandro Capucci, A John Camm, S Bertil Olsson, Dietrich Andresen, D Wyn Davies, Stuart Cobbe, Günter Breithardt, Jean-Yves Le Heuzey, Martin H Prins, Samuel Lévy, Harry J G M Crijns et al.
AIMS: To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines. METHODS AND RESULTS: Among 182 hospitals in 35 countries, 5333 ambulant and hospitalized AF patients were enrolled, in 2003 and 2004. AF was primary or secondary diagnosis, and was confirmed on ECG in the preceding 12 months. Clinical type of AF was reported to be first detected in 978, paroxysmal in 1517, persistent in 1167, and permanent in 1547 patients...
November 2005: European Heart Journal
H J G M Crijns
Stroke is the most important complication of atrial fibrillation. The new practice guideline 'Atrial fibrillation' from the Dutch College of General Practitioners strongly advocates active detection of atrial fibrillation and antithrombotic treatment guided by stroke-risk stratification in order to decrease the risk of stroke. The stratification scheme it proposes skips age as a parameter. Instead, the general practitioners propose exclusive use of clinical risk factors such as previous stroke, hypertension, heart failure, coronary artery disease and diabetes...
July 17, 2004: Nederlands Tijdschrift Voor Geneeskunde
Murray Esler, Marlies Alvarenga, Gavin Lambert, David Kaye, Jacqui Hastings, Garry Jennings, Margaret Morris, Rosemary Schwarz, Jeff Richards
Panic disorder serves as a clinical model for testing whether mental stress can cause heart disease. Our own cardiologic management of panic disorder provides case material of recurrent emergency room attendances with angina and electrocardiogram ischemia, triggered arrhythmias (atrial fibrillation, ventricular fibrillation), and documented coronary artery spasm, in some cases with coronary spasm being complicated by coronary thrombosis. Application of radiotracer catecholamine kinetics and clinical microneurography methodology suggests there is a genetic predisposition to panic disorder that involves faulty neuronal norepinephrine uptake, possibly sensitizing the heart to symptom generation...
June 2004: Annals of the New York Academy of Sciences
Bernhard R Winkelmann
The Annual Scientific Sessions of the American Heart Association is the leading scientific conference in the cardiovascular field, both for basic and clinical research in cardiology and related disclipines. This report covers the outcome of major clinical trials that were presented in the 'late-breaking' clinical trial sessions. The Valsartan in Acute Myocardial Infarction Trial (VALIANT) investigated the angiotensin receptor blocker valsartan, the angiotensin-converting enzyme inhibitor captopril, and their combination in 14,703 survivors of an acute myocardial infarction with a reduced left ventricular ejection fraction on clinical outcome...
April 2004: Expert Opinion on Investigational Drugs
Nenad Lakusić, Darija Mahović, Tomislav Babić, Davor Sporis
BACKGROUND AND PURPOSE: Heart rate variability (HRV) is a physiological phenomenon which reflects the influence of the autonomic nervous system on the heart work. The research in HRV has not been limited to the domain of basic and clinical cardiology, mostly with the aim of stratifying the risks of sudden death from malignant arrhythmias among patients with myocardial infarction (MI), but over the past few years the research has been done and studies have been published also in the area of neurology...
2003: Acta Medica Croatica: C̆asopis Hravatske Akademije Medicinskih Znanosti
José María García-Acuña, José Ramón González-Juanatey, Eduardo Alegría Ezquerra, Isidoro González Maqueda, José Luis Listerri
INTRODUCTION AND OBJECTIVE: Atrial fibrillation is the most common arrhythmia seen in clinical practice. The objective of this study was to know the frequency of atrial fibrillation and the characteristics of patients with atrial fibrillation in the Cardiotens study. MATERIAL AND METHOD: A cross-section study with systematic selection of the study sample. All 32,051 outpatients seen on the same day by 1,159 physicians specialized in primary-care (79%) and cardiology (21%) were prospectively added to a database including history of cardiac disease (heart failure, coronary disease or atrial fibrillation), blood pressure, and ongoing treatment...
September 2002: Revista Española de Cardiología
S Lévy
Atrial fibrillation (AF) is a common clinical problem, particularly in the elderly and in patients with organic heart disease. AF generally is classified into paroxysmal and chronic forms. Chronic AF can be the end result of paroxysmal AF in about 30% of patients. Paroxysmal AF can be defined as attacks of arrhythmia lasting < 7 days separated by prolonged periods of sinus rhythm. Chronic AF is AF established for > 7 days. Therefore, the differentiation of paroxysmal from chronic or established AF is based on the history of recurrent episodes and the duration of the current episode of AF...
August 1998: Journal of Cardiovascular Electrophysiology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"